Jonathan Poole has sold GNCA and made no open-market buys since May 2017
CFO at Genocea Biosciences, Inc.
SEC CIK 0001604689 · Filings on SEC.gov ↗
$0Bought
$310KSold
NoneLast buy
Every filing
2 filings since May 2017, newest first
Filings come from SEC EDGAR. Not investment advice.